Nav: Home

California researchers awarded $100,000 Potamkin Prize for dementia research

March 23, 2017

BOSTON - The American Academy of Neurology is awarding two California researchers the 2017 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases for their work in dementia research. Claudia Kawas, MD, of the University of California, Irvine, and Kristine Yaffe, MD, of the University of California, San Francisco, both members of the American Academy of Neurology, will be honored at the American Academy of Neurology's 69th Annual Meeting in Boston.

Sometimes referred to as the Nobel Prize of Alzheimer's research, the Potamkin Prize honors researchers for their work in helping to advance the understanding of Pick's disease, Alzheimer's disease and related disorders. The $100,000 prize is an internationally recognized tribute for advancing dementia research.

Kawas and Yaffe, who work independently of each other, will be recognized for their research on the epidemiology of Alzheimer's and other dementias.

Kawas will be recognized for her dementia research on people who are 90 years old and older, called the "oldest-old." More than 1,700 people have enrolled in her 90+ Study, one of the largest studies of the oldest-old in the world. Despite being the fastest growing population segment throughout much of the world, little is known about these pioneers of aging.

"More than half of the children born in developed countries today are expected to reach their 100th birthday or more," Kawas said. "Preventing dementia and improving quality of life as we age will benefit all of us individually, as well as have an enormous public health and economic impact."

Yaffe's work focuses on the identification of modifiable risk factors, including cardiovascular and metabolic risk factors, sleep disturbances and traumatic brain injury. The results of her research in these areas highlight the critical role of modifiable risk factors, not just in late life, but across the lifespan. Her work also provides important insight into the pathways that increase dementia risk.

"Our research on modifiable risk factors for dementia prevention is important both for individual patients who are concerned about their cognitive health, and for public health prevention," Yaffe said. "Addressing these risk factors could be a fundamental component of our strategy for slowing down the dementia epidemic."

The Potamkin Prize is made possible by the philanthropic contributions of the Potamkin family of New York, Philadelphia and Miami. The goal of the prize is to help attract the best medical minds and most dedicated scientists in the world to the field of dementia research. The Potamkin family has been the Academy's single largest individual donor since 1988, providing more than $2 million to fund the Potamkin Prize.
-end-
Learn more about dementia and related diseases at http://www.aan.com/patients.

The American Academy of Neurology is the world's largest association of neurologists and neuroscience professionals, with 32,000 members. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, stroke, migraine, multiple sclerosis, concussion, Parkinson's disease and epilepsy.

For more information about the American Academy of Neurology, visit http://www.aan.com or find us on Facebook, Twitter, Google+, LinkedIn and YouTube.

Media Contacts: Renee Tessman, rtessman@aan.com, (612) 928-6137
Michelle Uher, muher@aan.com, (612) 928-6120

American Academy of Neurology

Related Neurology Articles:

What are the financial barriers to adherence to treatment in neurology?
Though there is a growing armamentarium of medical therapies to treat neurological disease, patient adherence to taking the medication is critical to their effectiveness.
Nanomaterials for neurology: State-of-the-art
Despite the numerous challenges associated with the application of nanotechnology in neuroscience, it promises to have a significant impact on our understanding of how the nervous system works, how it fails in disease, and the development of earlier and less-invasive diagnostic procedures so we can intervene in the preclinical stage of neurological disease before extensive neurological damage has taken place.
Loyola neurologist is co-author and editor of four new neurology textbooks
Loyola Medicine neurologist José Biller, M.D., is a co-author, editor and co-editor of new editions of four major neurology textbooks that are helping physicians keep abreast with the ever expanding knowledge of neurological diseases and disorders.
American Academy of Neurology, American Brain Foundation and MDA offer new research award
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
The Lancet Neurology: For the first time, air pollution emerges as a leading risk factor for stroke worldwide
Air pollution -- including environmental and household air pollution -- has emerged as a leading risk factor for stroke worldwide, associated with about a third of the global burden of stroke in 2013, according to a new study published in The Lancet Neurology journal.
The Lancet Neurology: Scientists discover unique pattern of hidden brain damage in male soldiers exposed to high explosive blasts
Scientists have identified a distinctive pattern of injury in the brains of eight deceased military personnel who survived high explosive attacks and died between four days and nine years later from their injuries or other causes.
How 2 neurologists conceived a revolutionary new textbook of hospital neurology
'The Hospital Neurology Book' is a practical, comprehensive and groundbreaking guide to neurology in the hospital setting.
New edition of landmark neurology textbook
For 26 years, the classic neurology textbook Bradley's Neurology in Clinical Practice has been an essential resource for practicing neurologists and trainees.
Oxford University Press to publish Journal of Neuropathology & Experimental Neurology
Beginning January 2016, Oxford University Press (OUP) is the proud publisher of the prestigious Journal of Neuropathology & Experimental Neurology (JNEN).
New partnership provides free access to 6 vital neurology journals
Future Science Group has announced that all articles from six of their top neurology journals will now be free to access for members of Neurology Central.

Related Neurology Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...